Literature DB >> 33766871

The emerging plasticity of SARS-CoV-2.

Kevin D McCormick1, Jana L Jacobs1, John W Mellors2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33766871     DOI: 10.1126/science.abg4493

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  35 in total

1.  Dominance of Alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City.

Authors:  Ralf Duerr; Dacia Dimartino; Christian Marier; Paul Zappile; Guiqing Wang; Jennifer Lighter; Brian Elbel; Andrea B Troxel; Adriana Heguy
Journal:  J Clin Invest       Date:  2021-09-15       Impact factor: 14.808

2.  Phylogenomics and population genomics of SARS-CoV-2 in Mexico during the pre-vaccination stage reveals variants of interest B.1.1.28.4 and B.1.1.222 or B.1.1.519 and the nucleocapsid mutation S194L associated with symptoms.

Authors:  Francisco Barona-Gómez; Luis Delaye; Erik Díaz-Valenzuela; Fabien Plisson; Arely Cruz-Pérez; Mauricio Díaz-Sánchez; Christian A García-Sepúlveda; Alejandro Sanchez-Flores; Rafael Pérez-Abreu; Francisco J Valencia-Valdespino; Natali Vega-Magaña; José Francisco Muñoz-Valle; Octavio Patricio García-González; Sofía Bernal-Silva; Andreu Comas-García; Angélica Cibrián-Jaramillo
Journal:  Microb Genom       Date:  2021-11

Review 3.  Structural and functional insights into the spike protein mutations of emerging SARS-CoV-2 variants.

Authors:  Deepali Gupta; Priyanka Sharma; Mandeep Singh; Mukesh Kumar; A S Ethayathulla; Punit Kaur
Journal:  Cell Mol Life Sci       Date:  2021-11-03       Impact factor: 9.261

Review 4.  Immunizing the imperfect immune system: Coronavirus disease 2019 vaccination in patients with inborn errors of immunity.

Authors:  Jessica R Durkee-Shock; Michael D Keller
Journal:  Ann Allergy Asthma Immunol       Date:  2022-06-16       Impact factor: 6.248

5.  Improving the Outcomes of Immunocompromised Patients With Coronavirus Disease 2019.

Authors:  Ghady Haidar; John W Mellors
Journal:  Clin Infect Dis       Date:  2021-09-15       Impact factor: 9.079

Review 6.  The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic.

Authors:  Sarah P Otto; Troy Day; Julien Arino; Caroline Colijn; Jonathan Dushoff; Michael Li; Samir Mechai; Gary Van Domselaar; Jianhong Wu; David J D Earn; Nicholas H Ogden
Journal:  Curr Biol       Date:  2021-06-23       Impact factor: 10.834

Review 7.  Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19.

Authors:  Hong Zhou; Wei-Jian Ni; Wei Huang; Zhen Wang; Ming Cai; Yan-Cai Sun
Journal:  Front Immunol       Date:  2022-04-05       Impact factor: 8.786

8. 

Authors:  Hardy-Thorsten Panknin; Matthias Trautmann
Journal:  Procare       Date:  2021-06-18

Review 9.  Dynamically adjusted strategy in response to developments in the COVID-19 pandemic as a new normal.

Authors:  Weifeng Shen
Journal:  Global Health       Date:  2021-08-09       Impact factor: 4.185

10.  Screening of wild deer populations for exposure to SARS-CoV-2 in the United Kingdom, 2020-2021.

Authors:  Maya Holding; Ashley David Otter; Stuart Dowall; Katsuhisa Takumi; Bethany Hicks; Tom Coleman; Georgia Hemingway; Matthew Royds; Stephen Findlay-Wilson; Mollie Curran-French; Richard Vipond; Hein Sprong; Roger Hewson
Journal:  Transbound Emerg Dis       Date:  2022-04-08       Impact factor: 4.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.